Ebola virus: Experts fear ‘EXPLOSIVE’ increase in cases as outbreak hits MAJOR Congo city


The outbreak started on May 8 in the standoffish rural area of Bikoro and authorities say the 514 who may have been infected are being keep an eye oned.

But now three cases, one of which has been laboratory confirmed, have been related in Mbandaka, a densely populated city with poor sanitation and widely dispersed healthcare facilities.

A team of UK doctors, advisers and medical professionals put together by Notorious Health England (PHE) is expected to be deployed into the region within the next 48 hours.

So far, at least 44 people make been infected and 23 have died since the outbreak started, although qualifies fear many more cases may have gone unreported.

But the Magic Health organisation (WHO) fears the possibility of a full-blown health crisis as the ghostly disease moves into urbanised areas.

Senior WHO official Peter Salama suggested: “This is a major development in the outbreak.

A man works at a centre for Ebola in CongoGETTY

The WHO fears a huge proliferate in the current Congolese Ebola outbreak

“We have urban Ebola, which is a remarkably different animal from rural Ebola. The potential for an explosive extend in cases is now there.”

The county director for DRC at UK charity Oxfam said it was in all probability the disease had been carried into the city down the river Congo, the territory’s main artery.

The river connects Mbandaka with the DRC capital borough, Kinshasa, as well as Brazzaville, the capital of Congo.

Jose Barahona said: “Yachts move up and down the river, carrying people and goods. One of the risks is that someone with the virus could without a hitch access one of the boats and start moving up and down.

“If the number increases in Bikoro it’s bad but it’s not a catastrophe. But if these three cases in Mbandaka become 10 or 12 then we eat an urban epidemic.”

Reinforcing the WHO’s fears, Henry Gray, Médecins sans Frontières (MSF) pinch coordinator said: “It is paramount to trace the suspect case in order to make a clearer view on how it reached the city.

“We are working closely with the holy orders of health and the other organisations in the field to implement a coordinated, tailored and impetuous response to stop the spread of Ebola.”

Teams from MSF are have set up an isolation zone in the borough’s main hospital and are building two Ebola treatment centres with 20 beds each in Mbandaka and Bikoro, reports The Telegraph.

Ebola is spread utterly direct contact with bodily fluids, including blood, fret and spittle.

Ebola takes between two and three periods to develop once someone has been infected. Symptoms include upping, diarrhoea, decreased liver and kidney function and in extreme cases, internal and outward bleeding.

The latest outbreak is the ninth case of the disease in DRC since it was first off discovered in what was then Zaire in 1976 – but none of the previous outbreaks had reached a densely settled city.

The disease made international headline following a serious outbreak of the affliction between 2014-2016 across the west of the African continent, fatality 11,800 people in countries such as Guinea, Sierra Leone and Liberia.

At the period, the WHO was slow to respond after being criticised for ‘overreacting’ to the Swine Flu pandemic in 2009.

But now the WHO and other vital agencies have been deployed quickly.

These agencies bear also received funding from world governments and agencies, tabulating £3million from the Wellcome Trust and the Department for International Development in the UK.


Congo is in the sovereignty of an ebola crisis that has spread to an urban area for the first period ever

The first 4,000 batches of the VSV Ebola Vaccine arrived in the fatherland on Wednesday (May 16) and the World Health Organization, alongside the Congolese church elders of health, will begin a ring vaccination programme soon.

But the vaccine, which should be kept between minus 60 and minus 80 degrees celsius has sole so far been approved for emergency use.

John Edmunds, professor of infectious disability modelling at the London School of Hygiene and Tropical Medicine, said: “Officially it has to be participate in of some sort of research study because it’s not a licensed vaccine but there is a work-around so you can use it beneath special circumstances. They won’t be randomising people – everyone who needs it purposefulness get it.

“It’s a big headache to deliver the vaccine and keep it frozen. It is a major operation to get the trite chain up and running and to get it right out into the field.”

Leave a Reply

Your email address will not be published. Required fields are marked *